Zydus Lifesciences Q1 profit falls 36% to ₹940 crore

Zydus Lifesciences reported a 35.9% year-on-year fall in consolidated net profit to ₹940 crore in the June quarter, from ₹1,467 crore a year earlier. Revenue from operations rose 22% to ₹8,017 crore, but EBITDA declined 7.6% to ₹1,930 crore, pushing the EBITDA margin down to 24.1%.